Cargando…
Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer
Cisplatin-based chemoradiation is the standard treatment for cervical cancer, but chemosensitizing strategies are needed to improve patient survival. EGFR (Epidermal Growth Factor Receptor) is an oncogene overexpressed in cervical cancer that is involved in chemoresistance. Recent studies showed tha...
Autores principales: | Hugo de Almeida, Vitor, Guimarães, Isabella dos Santos, Almendra, Lucas R., Rondon, Araci M.R., Tilli, Tatiana M., de Melo, Andréia C., Sternberg, Cinthya, Monteiro, Robson Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078136/ https://www.ncbi.nlm.nih.gov/pubmed/30093972 http://dx.doi.org/10.18632/oncotarget.25748 |
Ejemplares similares
-
Interplay Between EGFR and the Platelet-Activating Factor/PAF Receptor Signaling Axis Mediates Aggressive Behavior of Cervical Cancer
por: Souza, Juliana L., et al.
Publicado: (2020) -
Novel Aspects of Extracellular Vesicles as Mediators of Cancer-Associated Thrombosis
por: Almeida, Vitor H., et al.
Publicado: (2019) -
Expression patterns of uPAR, TF and EGFR and their potential as targets for molecular imaging in oropharyngeal squamous cell carcinoma
por: Christensen, Anders, et al.
Publicado: (2022) -
Unraveling novel TF-miRNA regulatory crosstalk in metastasis of Soft Tissue Sarcoma
por: Samantarrai, Devyani, et al.
Publicado: (2015) -
Potential crosstalk between cofilin-1 and EGFR pathways in cisplatin resistance of non-small-cell lung cancer
por: Müller, Carolina Beatriz, et al.
Publicado: (2015)